MacroGenics Non Current Assets Total from 2010 to 2025

MGNX Stock  USD 2.77  0.21  7.05%   
MacroGenics Non Current Assets Total yearly trend continues to be fairly stable with very little volatility. Non Current Assets Total will likely drop to about 40.8 M in 2025. Non Current Assets Total is the total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets. View All Fundamentals
 
Non Current Assets Total  
First Reported
2012-12-31
Previous Quarter
44.2 M
Current Value
42.3 M
Quarterly Volatility
25.2 M
 
Yuan Drop
 
Covid
Check MacroGenics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MacroGenics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.3 M, Interest Expense of 1.7 M or Selling General Administrative of 37 M, as well as many indicators such as Price To Sales Ratio of 9.98, Dividend Yield of 0.0 or PTB Ratio of 3.69. MacroGenics financial statements analysis is a perfect complement when working with MacroGenics Valuation or Volatility modules.
  
Check out the analysis of MacroGenics Correlation against competitors.
For more information on how to buy MacroGenics Stock please use our How to Invest in MacroGenics guide.

Latest MacroGenics' Non Current Assets Total Growth Pattern

Below is the plot of the Non Current Assets Total of MacroGenics over the last few years. It is the total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets. MacroGenics' Non Current Assets Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MacroGenics' overall financial position and show how it may be relating to other accounts over time.
Non Current Assets Total10 Years Trend
Slightly volatile
   Non Current Assets Total   
       Timeline  

MacroGenics Non Current Assets Total Regression Statistics

Arithmetic Mean36,310,384
Geometric Mean23,505,318
Coefficient Of Variation70.07
Mean Deviation22,830,224
Median47,079,000
Standard Deviation25,443,183
Sample Variance647.4T
Range68.9M
R-Value0.79
Mean Square Error262.1T
R-Squared0.62
Significance0.0003
Slope4,215,197
Total Sum of Squares9710.3T

MacroGenics Non Current Assets Total History

202540.8 M
202454.1 M
202347.1 M
202258.3 M
202155.7 M
202066.1 M
201972.7 M

About MacroGenics Financial Statements

MacroGenics investors use historical fundamental indicators, such as MacroGenics' Non Current Assets Total, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in MacroGenics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Non Current Assets Total54.1 M40.8 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for MacroGenics Stock Analysis

When running MacroGenics' price analysis, check to measure MacroGenics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MacroGenics is operating at the current time. Most of MacroGenics' value examination focuses on studying past and present price action to predict the probability of MacroGenics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MacroGenics' price. Additionally, you may evaluate how the addition of MacroGenics to your portfolios can decrease your overall portfolio volatility.